Skip to main content
Fig. 5 | BMC Gastroenterology

Fig. 5

From: Premedication with reformulated simethicone and sodium bicarbonate improves mucosal visibility during upper gastrointestinal endoscopy: a double-blind, multicenter, randomized controlled trial

Fig. 5

a Incidences of complications during EGD (0: No symptoms; 1: Abdominal pain; 2: Distension; 3: Nausea; *P < 0.05, **P < 0.01). The incidence rates for abdominal pain and distension during EGD were significantly higher in Group B than in Group A. However, there was no significant difference between Group A and Group B in the percentage of patients who had no adverse response or nausea during EGD. b Incidence of complications after EGD (0: No symptoms; 1: Abdominal pain; 2: Distension; 3: Nausea; **P < 0.01). Abdominal pain, distension, and nausea after EGD occurred significantly more often in Group B than in Group A (P < 0.01). In addition, the percentage of patients who had no adverse response after EGD was significantly higher in Group A (P < 0.01)

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us